Very low birth weight infants receive full enteral nutrition within 2 postnatal weeks

Audrey Fenin1, Jill C Newman2, Sarah N Taylor3

  • 1Department of Pediatrics, Medical University of South Carolina, 10 McClennan Banks Drive, MSC 915, Charleston, SC, 29425, USA.

Insights

A revised feeding protocol enabled very low birth weight infants to reach full enteral feeds faster. This approach improved outcomes and reduced central line and parenteral nutrition days.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Evidence-Based Medicine

Background:

  • Establishing adequate enteral nutrition is critical for the growth and development of very low birth weight infants.
  • Traditional feeding protocols may lead to delayed achievement of full feeds, impacting infant outcomes.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of a new enteral nutrition goal for very low birth weight infants.
  • To determine if achieving full feeds by 7 days (for 1-1.5 kg infants) and 14 days (for <1 kg infants) is attainable.

Main Methods:

  • A retrospective cohort study comparing two epochs (before and after protocol implementation).
  • Infants were categorized into Epoch 1 (pre-protocol) and Epoch 2 (post-protocol).
  • Key outcomes included time to full feeds, central line days, parenteral nutrition duration, and infant growth.

Main Results:

  • Significantly higher rates of achieving full feeds in Epoch 2: 83% for 1-1.5 kg infants and 77% for <1 kg infants, versus 26% and 25% in Epoch 1 (p<0.0001).
  • Epoch 2 demonstrated significantly fewer central line and parenteral nutrition days.
  • Sustained and potentially improved infant growth was observed in Epoch 2.

Conclusions:

  • An evidence-based, advanced feeding protocol is associated with successful achievement of full enteral feeds within the first two postnatal weeks.
  • This protocol is feasible and beneficial for very low birth weight infants.
  • The findings support the implementation of optimized feeding protocols in neonatal intensive care units.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
556
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
866
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
514
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
134
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
531
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
144